<b>Background and Objective:</b> Tuberculosis (TB) is one of the leading causes of HIV-related death among people living with it. TB occurs more often severe in a weakened immune system, particularly when a patient is infected with HIV. People infected with HIV are 15-22 times more likely to fall ill with TB. In this research, an epitope-based vaccine has been specially designed for people living with HIV, since the current tuberculosis vaccine Bacillus Calmette-Guerin (BCG) has been proven to cause more harm than good in treating patients suffering from poor immune systems. <b>Materials and Methods:</b> The epitopes were selected from polysaccharide-protein of Mycobacterium tuberculosis and protein envelope of the Human immunodeficiency virus. B cell epitopes have been predicted using BepiPred 2.0, while T cell epitopes predicted using SMM, both are provided by Immune Epitope Database (IEDB). <b>Results:</b> This research had designed vaccine combinations for each type of epitopes and types of the pathogen with world population coverage of >85% for MHC class I epitopes and >99% for MHC class II epitopes. <b>Conclusion:</b> With each epitope were selected based on how strong its bond with HLA and how many HLA can bind with it. As this research was done through <i>in silico</i> approach, <i>in vivo</i> test is still needed to guarantee the result of the designed vaccine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3923/pjbs.2021.765.772 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multi-epitope Based Peptide Vaccine Candidate Against Infection From Rhoptry-Associated Protein 1 (RAP-1) Antigen Using Immuno-Informatics: An Approach.
Bioinform Biol Insights
December 2024
Discipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Objective: Babesiosis is a significant haemoparasitic infection caused by apicomplexan parasites of the genus . This infection has continuously threatened cattle farmers owing to its devastating effects on productivity and severe economic implications. Failure to curb the increase of the infection has been attributed to largely ineffective vaccines.
View Article and Find Full Text PDFPrediction of antigenic peptides of SARS- CoV-2 pathogen using machine learning.
PeerJ Comput Sci
October 2024
Department of Electrical & Electronics Engineering Faculty of Engineering and the Built Environment, University of Johannesburg, Johannesburg, South Africa.
Antigenic peptides (APs), also known as T-cell epitopes (TCEs), represent the immunogenic segment of pathogens capable of inducing an immune response, making them potential candidates for epitope-based vaccine (EBV) design. Traditional wet lab methods for identifying TCEs are expensive, challenging, and time-consuming. Alternatively, computational approaches employing machine learning (ML) techniques offer a faster and more cost-effective solution.
View Article and Find Full Text PDFDesign of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches.
PLoS One
December 2024
School of Life Science and Technology, Institut Teknologi Bandung, Bandung, West Java, Indonesia.
Article Synopsis
- The primary challenge in chronic hepatitis B is the immune system's inability to eliminate the cccDNA associated with the virus.
- Researchers are working on a new therapeutic vaccine utilizing a multi-epitope approach based on HBc and HBx proteins to target various HBV genotypes.
- This vaccine candidate shows potential for strong immune responses, global effectiveness, and stability, indicating significant progress in combating chronic hepatitis B.
Immunoinformatic approach to design T cell epitope-based chimeric vaccine targeting multiple serotypes of dengue virus.
J Biomol Struct Dyn
November 2024
Amity Institute of Virology & Immunology, Amity University Uttar Pradesh, Noida, India.
The global dengue outbreak is a significant public health concern, with the World Health Organization recording over 3 million cases and a 0.04% case fatality rate until July 2023. The infection rate is anticipated to rise in vulnerable regions worldwide.
View Article and Find Full Text PDFA novel pan-epitope based nanovaccine self-assembled with CpG enhances immune responses against flavivirus.
J Nanobiotechnology
November 2024
College of Basic Medicine, Army Medical University, Gaotanyan str. 30, Chongqing, 400038, China.
Article Synopsis
- Flavivirus infections are widespread and pose significant public health risks, necessitating the urgent development of a safe and effective vaccine, with the self-assembled pan-epitope vaccine being a promising approach.* -
- The study created a nanovaccine called TBT-CpG NaVs, which was found to be stable and effectively taken up by immune cells, enhancing their ability to present antigens and trigger an immune response.* -
- In tests, TBT-CpG NaVs increased specific antibody levels and showed protective benefits against Dengue and Zika viruses, with a good safety profile and no detected organ damage in vaccinated mice, indicating its potential for future vaccine development.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!